Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Merck
Queensland Health
Johnson and Johnson
QuintilesIMS
UBS
Accenture
Dow
Cipla
Harvard Business School

Generated: February 25, 2018

DrugPatentWatch Database Preview

Vanos Drug Profile

« Back to Dashboard

When do Vanos patents expire, and when can generic versions of Vanos launch?

Vanos is a drug marketed by Medicis and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.

This drug has eleven patent family members in nine countries.

The generic ingredient in VANOS is fluocinonide. There are nine drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the fluocinonide profile page.
Summary for Vanos
Drug patent expirations by year for Vanos
Pharmacology for Vanos
Medical Subject Heading (MeSH) Categories for Vanos

US Patents and Regulatory Information for Vanos

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis VANOS fluocinonide CREAM;TOPICAL 021758-001 Feb 11, 2005 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Medicis VANOS fluocinonide CREAM;TOPICAL 021758-001 Feb 11, 2005 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Medicis VANOS fluocinonide CREAM;TOPICAL 021758-001 Feb 11, 2005 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Medicis VANOS fluocinonide CREAM;TOPICAL 021758-001 Feb 11, 2005 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for VANOS
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Cream 0.10% ➤ Subscribe 1/31/2008

Non-Orange Book US Patents for Vanos

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,217,422 Compositions and methods for enhancing corticosteroid delivery ➤ Sign Up
7,771,733 Compositions and methods for enhancing corticosteroid delivery ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Vanos

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
UBS
Moodys
US Department of Justice
Harvard Business School
Boehringer Ingelheim
Chubb
Deloitte
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot